Related Experiment Video
Updated: Jul 7, 2026
13:05
Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Omega-3 fatty acids for cardioprotection
John H Lee1, James H O'Keefe, Carl J Lavie
1Mid America Heart Institute and University of Missouri-Kansas City, 4330 Wornall Road, Kansas City, MO 64111, USA.
Mayo Clinic Proceedings
|March 5, 2008
Summary
Increasing omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid) significantly reduces cardiovascular events. Supplementation is recommended, especially for those with or at risk for heart disease.
Area of Science:
- Cardiovascular Medicine
- Nutritional Science
- Pharmacology
Background:
- Omega-3 fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are recognized for potential cardiovascular benefits.
- Evidence from large controlled trials supports their role in reducing cardiovascular events.
Purpose of the Study:
- To summarize the evidence for cardiovascular benefits of omega-3 fatty acids.
- To provide recommendations for intake levels in various patient populations.
- To evaluate combination therapy with statins.
Main Methods:
- Analysis of 3 large controlled trials involving over 32,000 participants.
- Review of data on cardiovascular event reduction and triglyceride level changes.
- Assessment of safety and efficacy of omega-3 fatty acids, alone and with statins.
Main Results:
- Omega-3 fatty acid supplementation reduced cardiovascular events by 19% to 45%.
- Target intake is approximately 1 g/d for coronary artery disease patients and 500 mg/d for others.
- Doses of 3-4 g/d significantly lowered triglycerides (20-50%) in hypertriglyceridemia patients.
- Combination therapy with statins improved lipid levels and cardiovascular prognosis.
Conclusions:
- Increased intake of omega-3 fatty acids (DHA and EPA) is recommended for cardiovascular health, particularly for those with or at risk for coronary artery disease.
- Fish oil supplements are often necessary to achieve therapeutic levels, especially for secondary prevention and hypertriglyceridemia.
- Omega-3s offer benefits beyond statin therapy, suggesting a role in comprehensive cardiovascular management.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
03:38Structure of Lipids
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:31Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...